DCGAN-DTA: Predicting drug-target binding affinity with deep convolutional generative adversarial networks

DOI: https://doi.org/10.1186/s12864-024-10326-x
IF: 4.547
2024-05-10
BMC Genomics
Abstract:In recent years, there has been a growing interest in utilizing computational approaches to predict drug-target binding affinity, aiming to expedite the early drug discovery process. To address the limitations of experimental methods, such as cost and time, several machine learning-based techniques have been developed. However, these methods encounter certain challenges, including the limited availability of training data, reliance on human intervention for feature selection and engineering, and a lack of validation approaches for robust evaluation in real-life applications.
genetics & heredity,biotechnology & applied microbiology
What problem does this paper attempt to address?